Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation
Main Author: | |
---|---|
Publication Date: | 2023 |
Other Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | https://hdl.handle.net/10316/111997 https://doi.org/10.1016/j.jlr.2023.100419 |
Summary: | Oxidation of PUFAs in LDLs trapped in the arterial intima plays a critical role in atherosclerosis. Though there have been many studies on the atherogenicity of oxidized derivatives of PUFA-esters of cholesterol, the effects of cholesteryl hemiesters (ChEs), the oxidation end products of these esters, have not been studied. Through lipidomics analyses, we identified and quantified two ChE types in the plasma of CVD patients and identified four ChE types in human endarterectomy specimens. Cholesteryl hemiazelate (ChA), the ChE of azelaic acid (n-nonane-1,9-dioic acid), was the most prevalent ChE identified in both cases. Importantly, human monocytes, monocyte-derived macrophages, and neutrophils exhibit inflammatory features when exposed to subtoxic concentrations of ChA in vitro. ChA increases the secretion of proinflammatory cytokines such as interleukin-1β and interleukin-6 and modulates the surface-marker profile of monocytes and monocyte-derived macrophage. In vivo, when zebrafish larvae were fed with a ChA-enriched diet, they exhibited neutrophil and macrophage accumulation in the vasculature in a caspase 1- and cathepsin B-dependent manner. ChA also triggered lipid accumulation at the bifurcation sites of the vasculature of the zebrafish larvae and negatively impacted their life expectancy. We conclude that ChA behaves as an endogenous damage-associated molecular pattern with inflammatory and proatherogenic properties. |
id |
RCAP_33e05bab4b69b7ac4285b5a71250b180 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/111997 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammationcholesteryl hemiesterscholesteryl hemiazelateslipidomicsinnate inflammatory responsesatherosclerosisAnimalsHumansCholesterol EstersMonocytesInflammationEstersZebrafishAtherosclerosisOxidation of PUFAs in LDLs trapped in the arterial intima plays a critical role in atherosclerosis. Though there have been many studies on the atherogenicity of oxidized derivatives of PUFA-esters of cholesterol, the effects of cholesteryl hemiesters (ChEs), the oxidation end products of these esters, have not been studied. Through lipidomics analyses, we identified and quantified two ChE types in the plasma of CVD patients and identified four ChE types in human endarterectomy specimens. Cholesteryl hemiazelate (ChA), the ChE of azelaic acid (n-nonane-1,9-dioic acid), was the most prevalent ChE identified in both cases. Importantly, human monocytes, monocyte-derived macrophages, and neutrophils exhibit inflammatory features when exposed to subtoxic concentrations of ChA in vitro. ChA increases the secretion of proinflammatory cytokines such as interleukin-1β and interleukin-6 and modulates the surface-marker profile of monocytes and monocyte-derived macrophage. In vivo, when zebrafish larvae were fed with a ChA-enriched diet, they exhibited neutrophil and macrophage accumulation in the vasculature in a caspase 1- and cathepsin B-dependent manner. ChA also triggered lipid accumulation at the bifurcation sites of the vasculature of the zebrafish larvae and negatively impacted their life expectancy. We conclude that ChA behaves as an endogenous damage-associated molecular pattern with inflammatory and proatherogenic properties.Elsevier2023-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://hdl.handle.net/10316/111997https://hdl.handle.net/10316/111997https://doi.org/10.1016/j.jlr.2023.100419eng00222275Domingues, Neuza S.Gaifem, JoanaMatthiesen, RuneSaraiva, Diana P.Bento, LuísMarques, André R. A.Soares, Maria I. L.Sampaio, JulioKlose, ChristianSurma, Michal A.Almeida, Manuel Lopes deRodrigues, GustavoGonçalves, Pedro AraújoFerreira, JorgeE Melo, Ryan GouveiaPedro, Luís MendesSimons, KaiMelo, Teresa M. V. D. Pinho eCabral, M. GuadalupeJacinto, AntónioSilvestre, RicardoVaz, Winchil L. C.Vieira, Otília V.info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-07-23T15:37:36Zoai:estudogeral.uc.pt:10316/111997Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T06:04:20.106291Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
title |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
spellingShingle |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation Domingues, Neuza S. cholesteryl hemiesters cholesteryl hemiazelates lipidomics innate inflammatory responses atherosclerosis Animals Humans Cholesterol Esters Monocytes Inflammation Esters Zebrafish Atherosclerosis |
title_short |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
title_full |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
title_fullStr |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
title_full_unstemmed |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
title_sort |
Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation |
author |
Domingues, Neuza S. |
author_facet |
Domingues, Neuza S. Gaifem, Joana Matthiesen, Rune Saraiva, Diana P. Bento, Luís Marques, André R. A. Soares, Maria I. L. Sampaio, Julio Klose, Christian Surma, Michal A. Almeida, Manuel Lopes de Rodrigues, Gustavo Gonçalves, Pedro Araújo Ferreira, Jorge E Melo, Ryan Gouveia Pedro, Luís Mendes Simons, Kai Melo, Teresa M. V. D. Pinho e Cabral, M. Guadalupe Jacinto, António Silvestre, Ricardo Vaz, Winchil L. C. Vieira, Otília V. |
author_role |
author |
author2 |
Gaifem, Joana Matthiesen, Rune Saraiva, Diana P. Bento, Luís Marques, André R. A. Soares, Maria I. L. Sampaio, Julio Klose, Christian Surma, Michal A. Almeida, Manuel Lopes de Rodrigues, Gustavo Gonçalves, Pedro Araújo Ferreira, Jorge E Melo, Ryan Gouveia Pedro, Luís Mendes Simons, Kai Melo, Teresa M. V. D. Pinho e Cabral, M. Guadalupe Jacinto, António Silvestre, Ricardo Vaz, Winchil L. C. Vieira, Otília V. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Domingues, Neuza S. Gaifem, Joana Matthiesen, Rune Saraiva, Diana P. Bento, Luís Marques, André R. A. Soares, Maria I. L. Sampaio, Julio Klose, Christian Surma, Michal A. Almeida, Manuel Lopes de Rodrigues, Gustavo Gonçalves, Pedro Araújo Ferreira, Jorge E Melo, Ryan Gouveia Pedro, Luís Mendes Simons, Kai Melo, Teresa M. V. D. Pinho e Cabral, M. Guadalupe Jacinto, António Silvestre, Ricardo Vaz, Winchil L. C. Vieira, Otília V. |
dc.subject.por.fl_str_mv |
cholesteryl hemiesters cholesteryl hemiazelates lipidomics innate inflammatory responses atherosclerosis Animals Humans Cholesterol Esters Monocytes Inflammation Esters Zebrafish Atherosclerosis |
topic |
cholesteryl hemiesters cholesteryl hemiazelates lipidomics innate inflammatory responses atherosclerosis Animals Humans Cholesterol Esters Monocytes Inflammation Esters Zebrafish Atherosclerosis |
description |
Oxidation of PUFAs in LDLs trapped in the arterial intima plays a critical role in atherosclerosis. Though there have been many studies on the atherogenicity of oxidized derivatives of PUFA-esters of cholesterol, the effects of cholesteryl hemiesters (ChEs), the oxidation end products of these esters, have not been studied. Through lipidomics analyses, we identified and quantified two ChE types in the plasma of CVD patients and identified four ChE types in human endarterectomy specimens. Cholesteryl hemiazelate (ChA), the ChE of azelaic acid (n-nonane-1,9-dioic acid), was the most prevalent ChE identified in both cases. Importantly, human monocytes, monocyte-derived macrophages, and neutrophils exhibit inflammatory features when exposed to subtoxic concentrations of ChA in vitro. ChA increases the secretion of proinflammatory cytokines such as interleukin-1β and interleukin-6 and modulates the surface-marker profile of monocytes and monocyte-derived macrophage. In vivo, when zebrafish larvae were fed with a ChA-enriched diet, they exhibited neutrophil and macrophage accumulation in the vasculature in a caspase 1- and cathepsin B-dependent manner. ChA also triggered lipid accumulation at the bifurcation sites of the vasculature of the zebrafish larvae and negatively impacted their life expectancy. We conclude that ChA behaves as an endogenous damage-associated molecular pattern with inflammatory and proatherogenic properties. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-09 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10316/111997 https://hdl.handle.net/10316/111997 https://doi.org/10.1016/j.jlr.2023.100419 |
url |
https://hdl.handle.net/10316/111997 https://doi.org/10.1016/j.jlr.2023.100419 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
00222275 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833602567120093184 |